VALERITAS HOLDINGS INC. VLRX Cash Flow

Valeritas holdings inc. (VLRX)

CashFlow / TTM

Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15
Operating activities
Net loss
-53,811	-52,098	-49,039	-45,929	-49,000	-48,047	-49,069	-49,301	-44,212	-42,791	-41,275	-46,367	-48,554	-53,891	-84,072	-67,195	0	0	0
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of property and equipment
1,231	1,204	1,264	1,264	1,449	1,616	1,728	1,900	2,245	2,151	2,092	2,041	0	0	0	-	-	-	-
Amortization of financing costs
25	25	23	21	19	17	11	20	22	25	432	4,402	0	0	0	-	-	-	-
Noncash interest expense
2,962	3,631	4,275	4,162	4,045	3,936	3,854	4,438	5,018	5,652	6,730	7,760	0	0	0	-	-	-	-
Share-based compensation expense
3,578	3,899	4,097	4,057	4,062	4,607	5,183	5,583	5,008	4,305	4,660	3,792	0	0	0	-	-	-	-
Obsolete inventory reserve
0	0	0	-	0	0	0	-	-	0	0	-	-	-	0	-	-	-	-
Change in fair value of derivative liabilities
-	-	-	-	-	-	-	221	333	252	242	-549	0	0	0	-	-	-	-
Deferred revenue reduction
-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-
Sales return provision
-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-
Sales return provision
0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-
Accrued restructuring cost
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Changes in:
Accounts receivable
820	785	1,696	2,303	1,755	1,580	405	529	670	-309	303	474	0	0	0	-	-	-	-
Other receivables
-	-	-	-	-	-	-	-	-	-	307	-320	0	0	0	-	-	-	-
Accounts payable, related party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Interest payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Inventories
2,537	2,010	-229	-1,281	-1,663	-883	-148	-1,279	-1,749	-3,016	-3,311	-1,400	-372	283	2,108	1,196	0	0	0
Deferred cost of goods sold
-	-	-	-	-	-	-	-151	-394	20	-12	-173	0	0	0	-	-	-	-
Prepaid expense and other current assets
-17	55	-217	324	337	435	477	65	-24	-118	-288	-166	0	0	0	-	-	-	-
Other assets
242	240	129	264	68	61	4	-5	0	0	0	-	-	-	-	-	-	-	-
Amortization of debt discount
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Accounts payable
1,687	280	599	-1,017	-1,800	95	-836	1,053	2,073	3	-484	-2,828	-4,747	-2,090	1,516	3,343	0	0	0
Accrued expense
3,854	3,982	3,103	1,949	1,867	-61	622	279	-252	530	-597	-424	0	0	0	-	-	-	-
Deferred revenue
-	-	-	-	-	-	-	-	-	110	50	-272	0	0	0	-	-	-	-
Deferred rent liability
0	12	22	51	104	67	36	-12	-85	-77	0	-73	0	0	0	-	-	-	-
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	48,751	73,393	36,777	0	0	0	-	-	-	-
Net increase (decrease) in cash and cash equivalents
-	-	-	-	-	-	-	-	18,556	21,814	46,775	7,077	0	0	0	-	-	-	-
Net cash used in operating activities
-43,266	-41,526	-36,956	-37,190	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-27,027	-26,745	-29,661	0	0	0	-	-	-	-
Investing activities
Proceeds from sales of property and equipment
-	-	-	-	-	-	-	185	131	219	200	134	0	0	0	-	-	-	-
Acquisition of property and equipment
1,795	1,765	1,958	1,552	1,677	1,563	1,032	877	368	129	73	173	0	0	0	-	-	-	-
Net cash used in investing activities
-1,795	-1,765	-1,958	-1,552	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	90	127	-39	0	0	0	-	-	-	-
Financing activities
Repayment of finance lease
136	110	106	97	51	46	20	0	0	0	0	26	0	0	0	-	-	-	-
Proceeds from issuance of common stock and exercise of warrants, net of fees
40,984	34,411	58,087	57,294	27,549	27,548	-516	48,792	48,792	48,786	73,272	23,964	0	0	0	-	-	-	-
Proceeds from issuance of common stock through ESPP
0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-
Proceeds from issuance of Series AB ($5,819 received from related party CRG in 2016)
-	-	-	-	-	-	-	-	-	-	-	5,819	0	0	0	-	-	-	-
Proceeds from exercise of warrants by a related party
-	-	-	-	-	-	-	-	-	-	-	7,375	0	0	0	-	-	-	-
Costs associated with investor capital contributions
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Costs associated with debt restructuring
-	-	-	-	-	-	-	35	35	35	390	355	0	0	0	-	-	-	-
Repayment to loan payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Proceeds from loan payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Net cash provided by financing activities
43,954	37,506	61,186	60,539	0	0	0	-	-	-	-	-	-	-	-	-	-	-	0
Net decrease in cash and cash equivalents
0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Increase (decrease) in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Supplemental disclosures of cash flow information
Right-of-use assets
0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred rent
0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on sale of property and equipment
-	-	-	-	-	-	-	175	206	219	200	134	0	0	0	-	-	-	-
Deferred revenue reduction
0	0	0	1,638	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Deferred cost of goods sold reduction
0	0	0	539	539	539	539	0	0	0	0	-	-	-	-	-	-	-	-
Accrued distribution fees and managed care costs
0	0	0	343	343	343	343	0	0	0	0	-	-	-	-	-	-	-	-
Noncash investing and financing
Capital lease obligation
45	45	45	360	315	315	315	0	0	0	0	-	-	-	-	-	-	-	-
Accrued/payable offering costs
0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-
Accrued offering costs/acquisition related costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Write off of debt issuance costs
-	-	-	-	-	-	-	107	107	107	107	0	0	0	0	-	-	-	-
Related party conversion of debt to Series A preferred stock
-	-	-	-	-	-	-	27,500	27,500	27,500	27,500	0	0	0	0	-	-	-	-
Property and equipment additions included in accounts payable
0	0	0	-	0	0	0	-	-	-	-	-	-	-	0	-	-	-	-